1. Approved CAR T cell therapies: ice bucket challenges on glaring safety risks and long-term impacts. Issue 6 (June 2018) Authors: Zheng, Ping-Pin; Kros, Johan M.; Li, Jin Journal: Drug discovery today Issue: Volume 23:Issue 6(2018) Page Start: 1175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Circulating glioma biomarkers. (24th September 2014) Authors: Kros, Johan M.; Mustafa, Dana M.; Dekker, Lennard J.M.; Sillevis Smitt, Peter A.E.; Luider, Theo M.; Zheng, Ping-Pin Journal: Neuro-oncology Issue: Volume 17(2015)Supplement 3 Page Start: 343 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DNA-nanorobot-guided thrombin-inducing tumor infarction: raising new potential clinical concerns. Issue 6 (June 2020) Authors: Zheng, Kang; Kros, Johan M.; Li, Jin; Zheng, Ping-Pin Journal: Drug discovery today Issue: Volume 25:Issue 6(2020) Page Start: 951 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Elusive Neurotoxicity in T Cell-Boosting Anticancer Therapies. Issue 4 (April 2019) Authors: Zheng, Ping-Pin; Kros, Johan M.; Wang, Guanyu Journal: Trends in immunology Issue: Volume 40:Issue 4(2019) Page Start: 274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗